BAX Latest Headlines

Notable healthcare headlines for the week: AstraZeneca, CVS Health, and Moderna in focus

at seekingalpha.com (Sun, 15-Feb 9:05 AM)

Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Ultragenyx Pharmaceutical (RARE)

at www.tipranks.com (Fri, 13-Feb 10:50 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Artivion (AORT), West Pharmaceutical Services (WST) and Baxter International (BAX)

at www.tipranks.com (Fri, 13-Feb 6:40 AM)

Baxter's Q4 Results Highlight Shift to Innovation and International Growth Amid Ongoing Challenges

Market Chameleon (Thu, 12-Feb 7:32 AM)

Baxter International Earnings Call: Growth Meets Margin Squeeze

at www.tipranks.com (Thu, 12-Feb 7:18 PM)

Baxter outlines 2026 EPS target of $1.85–$2.05 and signals flat organic sales as company pursues turnaround

at seekingalpha.com (Thu, 12-Feb 1:15 PM)

Baxter slips following Q4 bottom line miss, weak 2026 EPS guidance

at seekingalpha.com (Thu, 12-Feb 10:05 AM)

Baxter International Reports Mixed Q4 Results and Outlook

at www.tipranks.com (Thu, 12-Feb 7:49 AM)

Baxter Non-GAAP EPS of $0.44 misses by $0.10, revenue of $2.97B beats by $150M

at seekingalpha.com (Thu, 12-Feb 7:17 AM)

Here are the major earnings before the open Thursday

at seekingalpha.com (Wed, 11-Feb 6:00 PM)

Baxter Q4 2025 Earnings Preview

at seekingalpha.com (Wed, 11-Feb 10:36 AM)

Baxter International: Discounted Valuation and Efficiency Upside Offset by Execution and Product Risk, Justifying Hold

at www.tipranks.com (Tue, 10-Feb 2:25 PM)